Ariston Pharmaceuticals, Inc. Report issue

For profit Phase 2
Founded: Framingham MA United States (2003)
Status: Acquired by Manhattan Pharmaceuticals (2010) → now TG Therapeutics, Inc. (2011)

Organization Overview

First Clinical Trial
2007
NCT00285402
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

hydroxocobalamin (cyanokit) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Headache (Phase 2)

Migraine Disorders (Phase 2)

Migraine with Aura (Phase 2)

Migraine without Aura (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1